1. Catalogs
  2. Randox Laboratories
  3. Cardiology & Lipid Testing

Cardiology & Lipid Testing

Cardiology & Lipid Testing
1 / 28 PagesView full catalog

Cardiology & Lipid Testing

Product catalog summary
Introduction
Randox offers a wide range of cardiology and lipid testing solutions known for their precision and quality. Their portfolio includes over 100 assays that cover various disease markers, allowing laboratories to expand their test menus without additional equipment, thereby reducing costs and minimizing errors.
Benefits of Randox Reagents
Randox reagents are praised for their accuracy and precision. They enable laboratories to expand test menus without extra equipment, reduce costs by minimizing waste, and bring testing in-house. These reagents are validated against gold-standard methods, ensuring reliable patient results.
Advanced Lipid Testing
Randox provides advanced lipid testing to improve patient treatment and reduce cardiovascular disease risks, offering reagents for both conventional risk factors and emerging biomarkers.
HDL and LDL Cholesterol Assays
The HDL Cholesterol Assay uses a direct clearance methodology for accurate results, even with abnormal samples, and is compatible with various analyzers. The LDL Cholesterol Assay also uses a direct clearance method, crucial for lipid reduction therapies, and overcomes limitations of traditional methods.
Total Cholesterol and Triglycerides
Randox offers assays for total cholesterol and triglycerides, essential for assessing overall cholesterol levels and associated health risks, with extensive measuring ranges compatible with various analyzers.
Small-Dense LDL Cholesterol (sdLDL-C)
The sdLDL-C assay provides quick results and correlates well with ultracentrifugation, offering a comprehensive understanding of cardiovascular risk.
Lipoprotein(a) [Lp(a)]
The Randox Lp(a) assay minimizes size-related bias and is standardized to WHO/IFCC reference material, playing a significant role in assessing CVD risk, especially in individuals with a family history of premature CVD.
Apolipoproteins
Various apolipoproteins are discussed, including Apolipoprotein A-I, A-II, B, C-II, C-III, and E, each with specific roles in cholesterol transport and cardiovascular risk.
sPLA2-IIA
This biomarker predicts coronary risk and adverse outcomes, contributing to atherosclerosis development.
Clinical Guidelines
European guidelines recommend measuring Lp(a) in high-risk individuals, with ICD-10 codes aiding in diagnosis and risk correlation.
Automated Biochemistry Analysers
Randox offers analysers designed for ease of use and reliable results, using liquid ready-to-use reagents and a Latex Enhanced Immunoturbidimetric method.
Homocysteine and High Sensitivity CRP Assays
The Homocysteine Assay ensures accurate results with limited interference, while the hsCRP Assay aids in assessing CVD risk, recommended by the American Heart Association and CDC.
CK-MB, Myoglobin, and Digoxin Assays
These assays are designed for ease of use and minimal waste, crucial for monitoring various cardiac conditions.
Familial Hypercholesterolaemia (FH) Arrays
Randox provides FH Arrays for rapid genetic testing, offering quick and cost-effective cascade testing.
Biochip Array Technology
This technology allows for multi-analyte testing from a single sample, providing comprehensive patient profiles for diagnostic and research purposes.
Cardiac Risk Prediction and Protein Arrays
These arrays enable genotyping and detection of multiple cardiac markers, aiding in early intervention and risk stratification.
Ordering Information
Ordering details and product availability vary by region, with specific performance information based on the Randox RX series of clinical analysers.
See more

Catalog excerpts

Cardiology & Lipid Testing-1

CARDIOLOGY & LIPID TESTING COMPLETE CARDIOLOGY & LIPID TESTING FROM RANDOX

 Open the catalog to page 1
Cardiology & Lipid Testing-2

CARDIOLOGY & LIPID TESTING Complete Cardiology and Lipid Testing from Randox

 Open the catalog to page 2
Cardiology & Lipid Testing-3

sdLDL CHOLESTEROL APOLIPOPROTEIN C-III DIAGNOSTIC BIOCHIP PRODUCTS RESEARCH BIOCHIP PRODUCTS ORDERING INFORMATION GLOBAL DIAGNOSTIC SOLUTIONS PROVIDER NP NICHE PRODUCT When you see this symbol you will know that Randox have one of the only automated biochemistry assays available on the market UF UNIQUE FEATURE When you see this symbol you will know that this feature is unique to the Randox product

 Open the catalog to page 3
Cardiology & Lipid Testing-4

BENEFITS OF RANDOX REAGENTS Randox offers an extensive range of third party diagnostic reagents which are internationally recognised as being of the highest quality; producing accurate and precise results. We have a considerable test menu of over 100 assays, covering over 100 disease markers including: antioxidants, diabetes, drugs of abuse testing, lipids, specific proteins, therapeutic drug monitoring and veterinary testing. EXPAND YOUR TEST MENU WITHOUT EXPANDING YOUR LAB There is no need to buy any extra equipment in order to expand your test menu. Our reagents can be programmed onto the...

 Open the catalog to page 4
Cardiology & Lipid Testing-5

INTRODUCTION TO RANDOX CARDIOLOGY AND LIPID TESTING International bodies, including the National Lipid Association and the European Guidelines on Cardiovascular Disease (CVD) Prevention in Clinical Practice advocate measuring lipids to truly identify CVD risk. However, the traditional lipid panel of cholesterol, HDL-C, triglycerides and LDL-C only detect approximately 20% of all coronary artery disease (CAD) patients. Advanced lipid testing is recommended to optimise patient treatment, both in primary and secondary risk categories and as such provide the necessary tools to prevent and reduce...

 Open the catalog to page 5
Cardiology & Lipid Testing-6

HDL CHOLESTEROL Clinical Significance Key Features of the Randox HDL Cholesterol Assay UF High-density lipoproteins (HDL) are one of the major classes of plasma lipoproteins. HDL-C is often referred to as ‘good cholesterol’ as it transports from the tissues to the liver for removal from the body. High levels of HDL-C can lower the risk of developing heart disease. Superior direct clearance methodology ensuring truly accurate results even with abnormal samples Liquid ready-to-use reagents for convenience and ease of use Extensive measuring range of 0.189 - 3.73mmol/L Applications available detailing...

 Open the catalog to page 6
Cardiology & Lipid Testing-7

Fig. 3 Specificity of Randox Direct Clearance Assay for HDL Cholesterol Specificity of the Randox direct clearance HDL-C assay was verified against gel filtration. Fig. 3 indicates how specific the Randox direct clearance method is for HDL-C. Our kit was found to only react with the HDL-C fractions separated by gel filtration. Total Cholesterol Reagent 1 Randox HDL Cholesterol Reagent THE DIAGRAM ABOVE SHOWS HOW SPECIFIC THE RANDOX DIRECT CLEARANCE METHOD IS All ordering information can be found on Page 20-2

 Open the catalog to page 7
Cardiology & Lipid Testing-8

LDL CHOLESTEROL Key Features of the Randox LDL Cholesterol Assay • • • • UF Superior direct clearance methodology ensuring truly accurate results are delivered Liquid ready-to-use reagents for convenience and ease-of-use Extensive measuring range of 0.189 – 22.2mmol/L for the measurement of clinically significant levels Applications available detailing instrument-specific settings for the convenient use of the Randox LDL Cholesterol (LDL-C) assay on a wide range of clinical chemistry analysers Benefits of the Randox Direct Clearance Method The Randox direct clearance method eliminates sample...

 Open the catalog to page 8
Cardiology & Lipid Testing-9

Fig. 5 Specificity of the Randox Direct Clearance Assay for LDL Cholesterol Specificity of the Randox direct clearance LDL-C assay was verified against gel filtration. Fig. 5 indicates how specific the Randox direct clearance method is for LDL-C. Our kit was found to only react with the LDL-C fractions separated by gel filtration. Randox LDL Cholesterol Total Cholesterol 1 THE FRIEDEWALD FORMULA HAS BEEN REPORTED TO MISCLASSIFY UP TO 50% OF PATIENTS3 % of samples misestimated by more than 10% All ordering information can be found on Page 20-2

 Open the catalog to page 9
Cardiology & Lipid Testing-10

TOTAL CHOLESTEROL & TRIGLYCERIDES Triglycerides: recommended levels below Cholesterol: recommended levels below CHOLESTEROL (TOTAL) Key Features of the Randox Cholesterol Assay Key Features of the Randox Triglycerides Assay Wide range of kits available ensuring laboratories of all sizes can find a product to suit their needs Liquid ready-to-use reagents for convenience and ease-of-use Standards included in certain kits for user convenience (these are for manual and semi-automated use only) Extensive measuring range of 0.865-16.6 mmol/L for the measurement of clinically significant levels Applications...

 Open the catalog to page 10
Cardiology & Lipid Testing-11

sdLDL CHOLESTEROL SMALL-DENSE LDL CHOLESTEROL (sdLDL-C) Fig. 6 Correlation of Ultracentrifugation and Denka Seiken Methods. 6 Key Features of the Randox sdLDL Cholesterol Assay Until recently, the primary methods of assessing a patient’s sdLDL-C levels were based on techniques such as ultracentrifugation and electrophoresis both of which are extremely laborious and time-consuming. 4 sdLDL-C can now be assessed in the routine biochemistry laboratory using the Randox Clearance assay. • Randox sdLDL-C utilises the clearance method which produces results in ten minutes. There are two main reaction...

 Open the catalog to page 11
Cardiology & Lipid Testing-12

Criteria to overcome challenges of Lp(a) measurement Traditional challenges of Lp(a) measurement The widespread use of Lp(a) as an independent risk factor for cardiovascular disease risk has, until recently, been impeded by the lack of internationally accepted standardisation and the fact that many commercial Lp(a) methods suffer from apolipoprotein (a) (apo(a)) size related bias, potentially leading to patient misclassification. The size heterogeneity of apo(a) affects, to varying degrees the results of many commercially available Lp(a) kits. This may result in an underestimation of Lp(a) in...

 Open the catalog to page 12
Cardiology & Lipid Testing-13

Clinical Significance The determination of Lp(a) levels is intended for use in conjunction with the clinical evaluation, patient risk assessment and other lipid tests to evaluate disorders of lipid metabolism and to assess coronary heart disease in specific populations. The size of the apo(a) protein is genetically determined and varies widely. As such, the levels of Lp(a) can vary up to 1000-fold between individuals.9 Recent years have seen major scientific advances in the understanding of Lp(a) and its causal role in premature cardiovascular disease (CVD). Elevated Lp(a) levels are associated...

 Open the catalog to page 13

All Randox Laboratories catalogs and technical brochures

  1. Acusera 24.7

    24  Pages

  2. sdLDL-C

    8  Pages

  3. RX modena

    20  Pages

  4. RX misano

    20  Pages

  5. RX Daytona Plus

    20  Pages

  6. Rx Imola

    20  Pages

  7. RX Monaco

    20  Pages

  8. VeraSTAT-V

    16  Pages

  9. VERASTAT

    16  Pages

  10. Qnostics

    52  Pages

  11. Linearity sets

    12  Pages

  12. Antioxidants

    16  Pages

  13. VIVALYTIC

    30  Pages

  14. HbA1c

    2  Pages

  15. Preparing QC

    1  Page

*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.